Sophia Lugo, CEO of Radar Therapeutics, and Eerik Kaseniit, Ph.D., CSO and President, dive into the exciting world of mRNA innovation. They share their journey from academia to industry, driven by a passion for equitable healthcare solutions. The duo discusses navigating co-founder dynamics and the importance of a supportive network in biotech. They also highlight how their precision-expressed mRNA technology is triggering interest from investors, positioning Radar as a key player in the evolving landscape of RNA therapeutics.
